PharmaShots Weekly Snapshots (June 10 – June 14, 2024)

This week PharmaShots’ news was all about the updates on Clinical Trials, Pharma, Biotech, COVID-19, Regulatory & MedTech. Check out our full report below:

Eli Lilly Reports the P-II (SYNERGY-NASH) Study Data of Tirzepatide for Treating Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Read More: Eli Lilly                                                                                                       

Moderna Reports the P-III Study Data of mRNA-1083 Vaccine Against Influenza and COVID-19

Read More: Moderna                                                                                                   

Junshi Biosciences Reports the P-III Trial Data of Toripalimab Plus Bevacizumab to Treat Advanced Hepatocellular Carcinoma (HCC)

Read More: Junshi Biosciences                                                                                   

Palatin Technologies Reports the Commencement of P-II Trial Evaluating Bremelanotide to Treat Obesity

Read More: Palatin Technologies                                                                               

Pfizer Reports the P-III Trial Data of Fordadistrogene Movaparvovec for Duchenne Muscular Dystrophy

Read More: Pfizer                                                                                                         

BeiGene to Highlight Data from P-III (SEQUOIA) Study of Brukinsa in Combination with Venetoclax for CLL/SLL at EHA2024

Read More: BeiGene                                                                                                 


Roche’s Alecensa (Alectinib) Receives the EC’s Approval as an Adjuvant Treatment for Early-Stage Lung Cancer

Read More: Roche                                                                                                        

GSK’s Arexvy Gains the US FDA’s Approval for Expanded Age Indication to Prevent RSV Lower Respiratory Tract Disease

Read More: GSK                                                                                                           

AstraZeneca Reports the US FDA’s sNDA Acceptance of Tagrisso to Treat Lung Cancer

Read More: AstraZeneca                                                                                               

Zymeworks Reports the NMPA’s BLA Acceptance of Zanidatamab to Treat Biliary Tract Cancer

Read More: Zymeworks                                                                                             

Ipsen’s Iqirvo (Elafibranor) Gains the US FDA’s Accelerated Approval for Treating Primary Biliary Cholangitis

Read More: Ipsen                                                                                                         

The US FDA Grants Emergency Use Authorization to Roche’s Four-In-One Nucleic Acid Test

Read More: Roche                                                                                                        

Regeneron’s Kevzara (Sarilumab) Gains the US FDA’s Approval to Treat Active Polyarticular Juvenile Idiopathic Arthritis (PJIA)

Read More: Regeneron                                                                                                 

The Canadian Intellectual Property Office (CIPO) Issues Notice of Allowance for Patent Covering Palisade Bio’s PALI-2108 for Treating Ulcerative Colitis

Read More: Palisade Bio                                                                                              

60 Degrees Pharmaceuticals’ Tafenoquine Gains the US FDA’s Orphan Drug Designation to Treat Acute Babesiosis

Read More: 60 Degrees Pharmaceuticals                                                              

AstraZeneca’s Farxiga (Dapagliflozin) Bags the US FDA’s Approval to Treat Type-2 Diabetes in Pediatric Patients

Read More: AstraZeneca                                                                                             

LEO Pharma’s Adbry (tralokinumab-ldrm) Autoinjector Receives the US FDA’s Approval to Treat Moderate-to-Severe Atopic Dermatitis (AD)

Read More: LEO Pharma                                                                                           

Innovent’s IBI343 Gains the US FDA’s Fast Track Designation to Treat Pancreatic Cancer

Read More: Innovent                                                                                                 

BMS Reports the US FDA’s Accelerated Approval of Augtyro to Treat Locally Advanced or Metastatic Solid Tumors

Read More: BMS                                                                                                        


Flagship Pioneering and ProFound Therapeutics Team Up with Pfizer to Discover Novel Therapies to Treat Obesity

Read More: Flagship Pioneering & ProFound                                                         

Ochre Bio and GSK Team Up to Explore the Drivers of Liver Disease

Read More: Ochre Bio & GSK                                                                                    

AbbVie Teams Up FutureGen to Advance Next-Generation Therapy to Address Inflammatory Bowel Disease

Read More: Abbvie                                                                                                       


DeepQure Reports the US FDA’s IDE Approval of HyperQure for Treating Resistant Hypertension

Read More: DeepQure                                                                                                 

The US FDA Clears Abbott’s Two New Over-The-Counter Continuous Glucose Monitoring Systems

Read More: Abbott                                                                                                    

Providence Medical’s CORUS Navigation Access System Gains the US FDA’s Clearance for Use in Posterior Spinal Fusion Procedures

Read More: Providence Medical                                                                                

Venus Medtech Reports First Implantation of the VenusP-Valve in its Pivotal Trial Across the US

Read More: Venus Medtech                                                                                   


Mira Pharmaceuticals Reports Preclinical Data of Ketamir-2 to Treat Depression

Read More: Mira Pharmaceuticals                                                                            


Alvotech and STADA Extend their Strategic Partnership Covering AVT03 (Biosimilar, Denosumab)

Read More: Alvotech & STADA                                                                                  


Moderna Reports the P-III Study Data of mRNA-1283 Vaccine to Prevent COVID-19

Read More: Moderna